Detalles de la búsqueda
1.
MCM-2 Levels as a Potential Biomarker for Predicting High-Risk Breast Cancer Patients According to TAILORx Classification.
Breast Cancer (Dove Med Press)
; 15: 659-669, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37674872
2.
Evaluation of Anti-Mullerian Hormone Levels, Antral Follicle Counts, and Mean Ovarian Volumes in Chemotherapy-Induced Amenorrhea among Breast Cancer Patients: A Prospective Clinical Study.
Curr Oncol
; 30(10): 9217-9229, 2023 10 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-37887566
Resultados
1 -
2
de 2
1
Próxima >
>>